Limb revascularization feasibility in diabetic patients with critical limb ischemia: Results from a cohort of 344 consecutive unselected diabetic patients evaluated in 2009

Ezio Faglia, Giacomo Clerici, Sergio Losa, Davide Tavano, Maurizio Caminiti, Marco Miramonti, Francesco Somalvico, Flavio Airoldi

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Aims: To evaluate the feasibility of peripheral revascularization by angioplasty (PTA) or bypass grafting (BPG) in diabetic patients with critical limb ischemia (CLI). Methods: All diabetic patients referred to our Diabetic Foot Centre for foot lesion or rest pain were assessed for the presence of CLI as assessed by the TASC criteria. All patients underwent angiography that was evaluated jointly by an interventional radiologist, a vascular surgeon and a diabetologist of the diabetic foot care team. Results: During 2009, 344 diabetics were admitted because of CLI in a total of 360 limbs. PTA was performed in 308 (85.6%) limbs, and BPG was performed in 40 (11.1%) limbs in which PTA was not feasible. Revascularization could not be carried out in 12 (3.3%) limbs due to the lack of target vessel (9 limbs) or high surgical risk (3 limbs).According to the judgement of the vascular surgeon, BPG was anatomically feasible in 180 (58.4%) of the 308 limbs that underwent PTA. Therefore, considering also the 40 limbs that underwent BPG, surgical revascularization was judged anatomically possible in a total of 220 (61.1%) limbs. At 30 days, 19 (5.3%) above-the-ankle amputations were performed: 8 (66.7%) amputations were performed in the 12 non-revascularized limbs, 8 (2.6%) amputations were performed in the 308 limbs treated with PTA and 3 (7.5%) amputations were performed in the 40 limbs treated with BPG. Conclusions: Revascularization by PTA is highly feasible in diabetics with CLI. The feasibility of revascularization by BPG is lower but nonetheless consistent. In centres where both revascularization procedures are available, it is possible to revascularize more than 96% of diabetics with CLI.

Original languageEnglish
Pages (from-to)364-371
Number of pages8
JournalDiabetes Research and Clinical Practice
Volume95
Issue number3
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Ischemia
Extremities
Amputation
Diabetic Foot
Blood Vessels
Angioplasty
Ankle
Foot
Angiography

Keywords

  • Critical limb ischemia
  • Diabetic foot
  • Diabetic Foot Centre
  • Peripheral angioplasty
  • Peripheral btpass graft
  • Peripheral ravascularization

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Endocrinology

Cite this

Limb revascularization feasibility in diabetic patients with critical limb ischemia : Results from a cohort of 344 consecutive unselected diabetic patients evaluated in 2009. / Faglia, Ezio; Clerici, Giacomo; Losa, Sergio; Tavano, Davide; Caminiti, Maurizio; Miramonti, Marco; Somalvico, Francesco; Airoldi, Flavio.

In: Diabetes Research and Clinical Practice, Vol. 95, No. 3, 03.2012, p. 364-371.

Research output: Contribution to journalArticle

@article{6b47acbd233141f796789e29fe04e783,
title = "Limb revascularization feasibility in diabetic patients with critical limb ischemia: Results from a cohort of 344 consecutive unselected diabetic patients evaluated in 2009",
abstract = "Aims: To evaluate the feasibility of peripheral revascularization by angioplasty (PTA) or bypass grafting (BPG) in diabetic patients with critical limb ischemia (CLI). Methods: All diabetic patients referred to our Diabetic Foot Centre for foot lesion or rest pain were assessed for the presence of CLI as assessed by the TASC criteria. All patients underwent angiography that was evaluated jointly by an interventional radiologist, a vascular surgeon and a diabetologist of the diabetic foot care team. Results: During 2009, 344 diabetics were admitted because of CLI in a total of 360 limbs. PTA was performed in 308 (85.6{\%}) limbs, and BPG was performed in 40 (11.1{\%}) limbs in which PTA was not feasible. Revascularization could not be carried out in 12 (3.3{\%}) limbs due to the lack of target vessel (9 limbs) or high surgical risk (3 limbs).According to the judgement of the vascular surgeon, BPG was anatomically feasible in 180 (58.4{\%}) of the 308 limbs that underwent PTA. Therefore, considering also the 40 limbs that underwent BPG, surgical revascularization was judged anatomically possible in a total of 220 (61.1{\%}) limbs. At 30 days, 19 (5.3{\%}) above-the-ankle amputations were performed: 8 (66.7{\%}) amputations were performed in the 12 non-revascularized limbs, 8 (2.6{\%}) amputations were performed in the 308 limbs treated with PTA and 3 (7.5{\%}) amputations were performed in the 40 limbs treated with BPG. Conclusions: Revascularization by PTA is highly feasible in diabetics with CLI. The feasibility of revascularization by BPG is lower but nonetheless consistent. In centres where both revascularization procedures are available, it is possible to revascularize more than 96{\%} of diabetics with CLI.",
keywords = "Critical limb ischemia, Diabetic foot, Diabetic Foot Centre, Peripheral angioplasty, Peripheral btpass graft, Peripheral ravascularization",
author = "Ezio Faglia and Giacomo Clerici and Sergio Losa and Davide Tavano and Maurizio Caminiti and Marco Miramonti and Francesco Somalvico and Flavio Airoldi",
year = "2012",
month = "3",
doi = "10.1016/j.diabres.2011.10.033",
language = "English",
volume = "95",
pages = "364--371",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Limb revascularization feasibility in diabetic patients with critical limb ischemia

T2 - Results from a cohort of 344 consecutive unselected diabetic patients evaluated in 2009

AU - Faglia, Ezio

AU - Clerici, Giacomo

AU - Losa, Sergio

AU - Tavano, Davide

AU - Caminiti, Maurizio

AU - Miramonti, Marco

AU - Somalvico, Francesco

AU - Airoldi, Flavio

PY - 2012/3

Y1 - 2012/3

N2 - Aims: To evaluate the feasibility of peripheral revascularization by angioplasty (PTA) or bypass grafting (BPG) in diabetic patients with critical limb ischemia (CLI). Methods: All diabetic patients referred to our Diabetic Foot Centre for foot lesion or rest pain were assessed for the presence of CLI as assessed by the TASC criteria. All patients underwent angiography that was evaluated jointly by an interventional radiologist, a vascular surgeon and a diabetologist of the diabetic foot care team. Results: During 2009, 344 diabetics were admitted because of CLI in a total of 360 limbs. PTA was performed in 308 (85.6%) limbs, and BPG was performed in 40 (11.1%) limbs in which PTA was not feasible. Revascularization could not be carried out in 12 (3.3%) limbs due to the lack of target vessel (9 limbs) or high surgical risk (3 limbs).According to the judgement of the vascular surgeon, BPG was anatomically feasible in 180 (58.4%) of the 308 limbs that underwent PTA. Therefore, considering also the 40 limbs that underwent BPG, surgical revascularization was judged anatomically possible in a total of 220 (61.1%) limbs. At 30 days, 19 (5.3%) above-the-ankle amputations were performed: 8 (66.7%) amputations were performed in the 12 non-revascularized limbs, 8 (2.6%) amputations were performed in the 308 limbs treated with PTA and 3 (7.5%) amputations were performed in the 40 limbs treated with BPG. Conclusions: Revascularization by PTA is highly feasible in diabetics with CLI. The feasibility of revascularization by BPG is lower but nonetheless consistent. In centres where both revascularization procedures are available, it is possible to revascularize more than 96% of diabetics with CLI.

AB - Aims: To evaluate the feasibility of peripheral revascularization by angioplasty (PTA) or bypass grafting (BPG) in diabetic patients with critical limb ischemia (CLI). Methods: All diabetic patients referred to our Diabetic Foot Centre for foot lesion or rest pain were assessed for the presence of CLI as assessed by the TASC criteria. All patients underwent angiography that was evaluated jointly by an interventional radiologist, a vascular surgeon and a diabetologist of the diabetic foot care team. Results: During 2009, 344 diabetics were admitted because of CLI in a total of 360 limbs. PTA was performed in 308 (85.6%) limbs, and BPG was performed in 40 (11.1%) limbs in which PTA was not feasible. Revascularization could not be carried out in 12 (3.3%) limbs due to the lack of target vessel (9 limbs) or high surgical risk (3 limbs).According to the judgement of the vascular surgeon, BPG was anatomically feasible in 180 (58.4%) of the 308 limbs that underwent PTA. Therefore, considering also the 40 limbs that underwent BPG, surgical revascularization was judged anatomically possible in a total of 220 (61.1%) limbs. At 30 days, 19 (5.3%) above-the-ankle amputations were performed: 8 (66.7%) amputations were performed in the 12 non-revascularized limbs, 8 (2.6%) amputations were performed in the 308 limbs treated with PTA and 3 (7.5%) amputations were performed in the 40 limbs treated with BPG. Conclusions: Revascularization by PTA is highly feasible in diabetics with CLI. The feasibility of revascularization by BPG is lower but nonetheless consistent. In centres where both revascularization procedures are available, it is possible to revascularize more than 96% of diabetics with CLI.

KW - Critical limb ischemia

KW - Diabetic foot

KW - Diabetic Foot Centre

KW - Peripheral angioplasty

KW - Peripheral btpass graft

KW - Peripheral ravascularization

UR - http://www.scopus.com/inward/record.url?scp=84857234289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857234289&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2011.10.033

DO - 10.1016/j.diabres.2011.10.033

M3 - Article

C2 - 22104261

AN - SCOPUS:84857234289

VL - 95

SP - 364

EP - 371

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 3

ER -